XML 69 R55.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Data - Financial Information for Company's Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Segment Reporting Information [Line Items]      
Revenues $ 21,840 $ 20,178 $ 19,372
Cost of products sold 11,915 11,053 11,202
Selling and administrative expense 5,278 4,857 4,719
Research and development expense 1,265 1,190 1,237
Other Operating Income (Expense), Net (396) (222) 210
Reconciliation of Operating Profit (Loss) from Segments to Consolidated 2,579 2,397 2,111
Integration, restructuring and transaction expense (408) (458) (313)
Income from Continuing Operations Before Income Taxes 1,881 2,005 1,662
Segment, Expenditure, Addition to Long-Lived Assets 760 725 874
Depreciation and amortization 2,462 2,286 2,288
Operating Segments      
Segment Reporting Information [Line Items]      
Revenues 21,840 20,245 19,372
Cost of products sold 9,666 9,245 8,858
Selling and administrative expense 3,030 2,679 2,599
Research and development expense 1,092 1,009 1,041
Other Operating Income (Expense), Net 17 (2) (16)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated 8,034 7,314 6,891
Operating Segments | Medical      
Segment Reporting Information [Line Items]      
Revenues 11,456 10,074 9,502
Cost of products sold $ 5,464 $ 5,015 $ 4,719
Cost of Products Sold as a Percent of Revenues 47.70% 49.80% 49.70%
Selling and administrative expense $ 1,312 $ 1,031 $ 993
Segment Selling and Administrative as a Percent of Revenues 11.50% 10.20% 10.40%
Research and development expense $ 523 $ 447 $ 445
Segment Research and Development as a Percent of Revenues 4.60% 4.40% 4.70%
Other Operating Income (Expense), Net $ 17 $ (2) $ (6)
Segment Other Operating Expense (Income), net as a Percent of Revenues 0.20% 0.00% (0.10%)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated $ 4,140 $ 3,583 $ 3,352
Segment Operating Income as a Percent of Revenues 36.10% 35.60% 35.30%
Segment, Expenditure, Addition to Long-Lived Assets $ 469 $ 438 $ 563
Depreciation and amortization 1,393 1,216 1,199
Operating Segments | Life Sciences      
Segment Reporting Information [Line Items]      
Revenues 5,167 5,191 5,133
Cost of products sold $ 2,490 $ 2,538 $ 2,489
Cost of Products Sold as a Percent of Revenues 48.20% 48.90% 48.50%
Selling and administrative expense $ 721 $ 702 $ 680
Segment Selling and Administrative as a Percent of Revenues 14.00% 13.50% 13.30%
Research and development expense $ 315 $ 336 $ 371
Segment Research and Development as a Percent of Revenues 6.10% 6.50% 7.20%
Other Operating Income (Expense), Net $ 0 $ 0 $ (6)
Segment Other Operating Expense (Income), net as a Percent of Revenues 0.00% 0.00% (0.10%)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated $ 1,641 $ 1,616 $ 1,599
Segment Operating Income as a Percent of Revenues 31.80% 31.10% 31.20%
Segment, Expenditure, Addition to Long-Lived Assets $ 121 $ 114 $ 139
Depreciation and amortization 261 272 277
Operating Segments | Interventional      
Segment Reporting Information [Line Items]      
Revenues 5,217 4,980 4,736
Cost of products sold $ 1,712 $ 1,693 $ 1,650
Cost of Products Sold as a Percent of Revenues 32.80% 34.00% 34.80%
Selling and administrative expense $ 997 $ 945 $ 926
Segment Selling and Administrative as a Percent of Revenues 19.10% 19.00% 19.60%
Research and development expense $ 255 $ 226 $ 225
Segment Research and Development as a Percent of Revenues 4.90% 4.50% 4.70%
Other Operating Income (Expense), Net $ 0 $ 0 $ (4)
Segment Other Operating Expense (Income), net as a Percent of Revenues 0.00% 0.00% (0.10%)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated $ 2,253 $ 2,115 $ 1,939
Segment Operating Income as a Percent of Revenues 43.20% 42.50% 40.90%
Segment, Expenditure, Addition to Long-Lived Assets $ 142 $ 127 $ 138
Depreciation and amortization 795 786 799
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment      
Segment Reporting Information [Line Items]      
Interest Income (Expense), Operating (575) (364) (403)
Purchase accounting adjustments (1,898) (1,503) (1,434)
Integration, restructuring and transaction expense (408) (458) (306)
Product, litigation, and other items (548) (346) (554)
Financing costs   8  
Separation-related items (97) (13) (14)
European regulatory initiative-related costs   (104) (139)
Corporate and All Other      
Segment Reporting Information [Line Items]      
Revenues 0 (67) 0
Operating Expenses (2,628) (2,529) (2,378)
Segment, Expenditure, Addition to Long-Lived Assets 28 46 35
Depreciation and amortization $ 14 $ 13 $ 13